The Peptrend Editorial team researches and writes every article on Peptrend.Health from the published literature. Each piece is checked against its cited sources before publication and updated when the research changes. The team works under the site's editorial policy: educational framing only, no medical advice, no dosing guidance, and plain statements about the strength of the evidence.
From a lizard-venom discovery in the 1990s to the most studied molecules in metabolic science. Here is what the published research actually shows, and where the field is heading next.
Purity percentages, mass spec identity, and the red flags a real COA never shows.
Hydration, elasticity, wrinkle depth. A plain reading of the trial data, the meta-analyses, and the funding question that changes how the results look.
NMN, NR, and what human trials have and have not demonstrated so far. A study-by-study look at a field where mouse data runs well ahead of human data.
Temperature, light, bacteriostatic water, and how degradation actually happens, explained for laboratory handling of research material.
The difference between a marketing term and a measurable standard, and the tests that turn one into the other.
A body-protection compound with hundreds of animal studies and very few human trials. Here is where the evidence actually stands, study by study.
Dual agonist against single agonist. What the SURPASS, SURMOUNT, and STEP trial programs measured, and how the two molecules differ at the receptor level.
Ipamorelin, CJC-1295, tesamorelin and the ghrelin axis. A map of the compound families and the studies behind each one.
One of the oldest peptides in cosmetic research. Wound models, follicle studies, and what the topical trial data supports.